AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2026
Feb 2, 2026
35599_dirs_2026-02-02_53d2aba1-f318-4c07-9718-29e6b9666b4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2026-02-02
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-02 | Common shares | M | 15598 | $2.45 | Acquired | 108826 | Direct |
| 2026-02-02 | Common shares | S | 10349 | $7.76 | Disposed | 98477 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | Stock Options | $2.45 | M | 15598 | Disposed | 2026-07-05 | options (15598) | Direct |
Footnotes
F1: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.
F2: Shares sold to satisfy tax obligation on option exercise.
F3: Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20